Single photon emission computed tomography (SPECT) in obsessive-compulsive disorder before and after treatment with inositol

被引:20
作者
Carey, PD [1 ]
Warwick, J
Harvey, BH
Stein, DJ
Seedat, S
机构
[1] Univ Stellenbosch, Dept Psychiat, MRC Res Unit Anxiety & Stress Disorders, ZA-7505 Tygerberg, Cape Town, South Africa
[2] Univ Stellenbosch, Dept Nucl Med, ZA-7505 Tygerberg, South Africa
[3] NW Univ, Sch Pharm, Div Pharmacol, Potchefstroom, South Africa
关键词
SPECT; OCD; inositol; treatment; brain-imaging;
D O I
10.1023/B:MEBR.0000027423.34733.12
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inositol, a glucose isomer and second messenger precursor, regulates numerous cellular functions and has demonstrated efficacy in obsessive-compulsive disorder (OCD) through mechanisms that remain unclear. The effect of inositol treatment on brain function in OCD has not been studied to date. Fourteen OCD subjects underwent single photon emission computed tomography (SPECT) with Tc-99m HMPAO before and after 12 weeks of treatment with inositol. Whole brain voxel-wise SPM was used to assess differences in perfusion between responders and nonresponders before and after treatment as well as the effect of treatment for the group as a whole. There was 1) deactivation in OCD responders relative to nonresponders following treatment with inositol in the left superior temporal gyrus, middle frontal gyrus and precuneus, and the right paramedian post-central gyrus; 2) no significant regions of deactivation for the group as a whole posttreatment; and 3) a single cluster of higher perfusion in the left medial prefrontal region in responders compared to nonresponders at baseline. Significant reductions in the YBOCS and CGI-severity scores followed treatment. These data are only partly consistent with previous functional imaging work on OCD. They may support the idea that inositol effects a clinical response through alternate neuronal circuitry to the SSRIs and may complement animal work proposing an overlapping but distinct mechanism of action.
引用
收藏
页码:125 / 134
页数:10
相关论文
共 43 条
[31]   Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers [J].
Mataix-Cols, D ;
Cullen, S ;
Lange, K ;
Zelaya, F ;
Andrew, C ;
Amaro, E ;
Brammer, MJ ;
Williams, SCR ;
Speckens, A ;
Phillips, ML .
BIOLOGICAL PSYCHIATRY, 2003, 53 (06) :482-493
[32]   FUNCTIONAL-ANATOMY OF OBSESSIVE-COMPULSIVE PHENOMENA [J].
MCGUIRE, PK ;
BENCH, CJ ;
FRITH, CD ;
MARKS, IM ;
FRACKOWIAK, RSJ ;
DOLAN, RJ .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 :459-468
[33]   NEW DEPRESSION SCALE DESIGNED TO BE SENSITIVE TO CHANGE [J].
MONTGOMERY, SA ;
ASBERG, M .
BRITISH JOURNAL OF PSYCHIATRY, 1979, 134 (APR) :382-389
[34]  
Nemets Boris, 2002, World J Biol Psychiatry, V3, P147, DOI 10.3109/15622970209150615
[35]   Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder [J].
Palatnik, A ;
Frolov, K ;
Fux, M ;
Benjamin, J .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (03) :335-339
[36]   A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder [J].
Pigott, TA ;
Seay, SM .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) :101-+
[37]   Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: A PET symptom provocation study [J].
Rauch, SL ;
Shin, LM ;
Dougherty, DD ;
Alpert, NM ;
Fischman, AJ ;
Jenike, MA .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (05) :782-791
[38]   Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder [J].
Russell, A ;
Cortese, B ;
Lorch, E ;
Ivey, J ;
Banerjee, SP ;
Moore, GJ ;
Rosenberg, DR .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 :S31-S38
[39]   Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression [J].
Saxena, S ;
Brody, AL ;
Ho, ML ;
Zohrabi, N ;
Maidment, KM ;
Baxter, LR .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (03) :522-532
[40]   Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression [J].
Saxena, S ;
Brody, AL ;
Ho, ML ;
Alborzian, S ;
Maidment, KM ;
Zohrabi, N ;
Ho, MK ;
Huang, SC ;
Wu, HM ;
Baxter, LR .
ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (03) :250-261